GADA Canada is dedicated to saving lives and enabling a promising future for individuals living with Marfan syndrome and other genetic aortic disorders through education, awareness, support and research. To succeed in these endeavours GADA is focusing on: 1. Promoting the creation of multidisciplinary aortic (MDA) clinics, centres of excellence for the treatment of all genetic aortic disorders across Canada. 2. Expediting the development of diagnostic criteria and treatment protocols for each and every genetic aortic disorder. In order to achieve this objective, in 2013 GADA organized an intensive three-day inaugural meeting that took place in Italy which resulted in the creation of the Montalcino Aortic Consortium (MAC). MAC is comprised of researchers and physicians who are specialists in genetic aortic disorders working on an international patient-registry research program